We refer to our earlier Letter No. FCIL/SEC/BSE/9666/2024-2025 dated 22nd May, 2025 informing you that the meeting of the Board of Directors is convened on Tuesday, 27th May, 2025 to consider ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts more than Nifty Microcap 250 and 2.7 pts more than its Investment Company peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board approved audited financial results for Q4 and FY25. On a standalone basis, FY25 revenue jumped to Rs. 216.71 lakhs from Rs. 97.97 lakhs in FY24 (over 2x growth), but profit fell to Rs. 43.08 lakhs from Rs. 51.34 lakhs as expenses quadrupled to Rs. 160.50 lakhs. Q4 standalone slipped into a small loss of Rs. 2.31 lakhs versus a Rs. 5.08 lakh profit in the year-ago quarter. On a consolidated basis (which now includes two subsidiaries and one LLP), FY25 revenue was Rs. 3,368.79 lakhs with a net profit of Rs. 266.47 lakhs, but Q4 posted a loss of Rs. 48.18 lakhs. The auditor (JMT & Associates) issued an unmodified (clean) opinion on the results. Operating cash flow improved standalone (+Rs. 27.76 lakhs vs -Rs. 218.02 lakhs prior year) but was deeply negative at the consolidated level (-Rs. 612.50 lakhs).
Mixed picture for shareholders — strong top-line growth, especially at the consolidated level from new subsidiaries (theatres, construction, real estate LLP), is encouraging, but sharp margin compression and a consolidated operating cash outflow raise concerns about profitability and cash quality. The standalone Q4 loss and the diluted EPS drop from Rs. 1.20 to Rs. 0.64 mean near-term earnings momentum is weak despite higher revenues.